Develops and commercializes immunotherapeutics for the treatment of cancer
Sector:
Health Technology
Industry:
Biotechnology
Employees:
11
Frequently Asked Questions
What is Market Cap of MabVax Therapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. MabVax Therapeutics Holdings Inc market cap is $3.09M.
What is the 52-week high for MabVax Therapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. MabVax Therapeutics Holdings Inc 52 week high is $3.27 as of September 13, 2025.
What is the 52-week low for MabVax Therapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. MabVax Therapeutics Holdings Inc 52 week low is $0.26 as of September 13, 2025.
What is MabVax Therapeutics Holdings Inc stock price today?
MabVax Therapeutics Holdings Inc stock price today is $0.50.
What was MabVax Therapeutics Holdings Inc stock price yesterday?
MabVax Therapeutics Holdings Inc stock price yesterday was $0.42.
What is the PE ratio of MabVax Therapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. MabVax Therapeutics Holdings Inc’s P/E ratio is None.
What is the Price-to-Book ratio of MabVax Therapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. MabVax Therapeutics Holdings Inc P/B ratio is 2.7563.
What is MabVax Therapeutics Holdings Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. MabVax Therapeutics Holdings Inc's EBITDA is N/A.
What is the 50-day moving average of MabVax Therapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. MabVax Therapeutics Holdings Inc 50-day moving average is $0.6474.
How many employess does MabVax Therapeutics Holdings Inc has?
MabVax Therapeutics Holdings Inc has 11 employees.